Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 451 AL 465

Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer's disease

Zakharova NV, Kononikhin AS, Indeykina MI, Bugrova AE, Strelnikova P, Pekov S, Kozin SA, Popov IA, Mitkevich V, Makarov AA, Nikolaev EN.

Mass Spectrom Rev. 2025 Jan-Feb;44(1):3-21. doi: 10.1002/mas.21775. Epub 2022 Mar 28.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.

Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies

Anitha K, Singh MK, Kohat K, Sri Varshini T, Chenchula S, Padmavathi R, Amerneni LS, Vishnu Vardhan K, Mythili Bai K, Chavan MR, Bhatt S.

Mol Neurobiol. 2025 Feb;62(2):2314-2332. doi: 10.1007/s12035-024-04384-1. Epub 2024 Aug 5.

Tetrameric Transthyretin as a Protective Factor Against Alzheimer's Disease

Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen YF, Panichella G, Musetti V, Castiglione V, Vergaro G, Emdin M, Franzini M.

Mol Neurobiol. 2025 Mar;62(3):2945-2954. doi: 10.1007/s12035-024-04442-8. Epub 2024 Aug 27.

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease

Liu Y, Zhang Z, Zhu Z, Yang Y, Peng W, Chen Q, Mak S, Tism KW, Pi R.

Mini Rev Med Chem. 2025;25(2):163-175. doi: 10.2174/0113895575330648240819112435.

Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

Kuşi M, Becer E, Vatansever HS.

Nutr Neurosci. 2025 May;28(5):550-562. doi: 10.1080/1028415X.2024.2397136. Epub 2024 Sep 3.

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Tang S, Zhang Y, Botchway BOA, Wang X, Huang M, Liu X.

Mol Neurobiol. 2025 Mar;62(3):3493-3507. doi: 10.1007/s12035-024-04498-6. Epub 2024 Sep 20.

Molecular Therapeutics in Development to Treat Alzheimer's Disease

Tartaglia MC, Ingelsson M.

Mol Diagn Ther. 2025 Jan;29(1):9-24. doi: 10.1007/s40291-024-00738-6. Epub 2024 Sep 24.

Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article

Alshiban A, Hasoglu T, Oster J.

Am J Geriatr Psychiatry. 2025 Feb;33(2):209-218. doi: 10.1016/j.jagp.2024.09.016. Epub 2024 Oct 3.

A Lipid-Raft Theory of Alzheimer's Disease

Rappoport A.

Annu Rev Biochem. 2025 Jun;94(1):387-416. doi: 10.1146/annurev-biochem-052024-115455. Epub 2024 Oct 30.

From defense to disease: IFITM3 in immunity and Alzheimer's disease

Kehs Z, Cross AC, Li YM.

Neurotherapeutics. 2025 Apr;22(3):e00482. doi: 10.1016/j.neurot.2024.e00482. Epub 2024 Nov 8.

The Amyloid Cascade Hypothesis: A Conclusion in Search of Support

Castellani RJ, Jamshidi P, Plascencia-Villa G, Perry G.

Am J Pathol. 2025 Nov;195(11):1988-1997. doi: 10.1016/j.ajpath.2024.10.014. Epub 2024 Nov 10.

Investigating interleukin-8 in Alzheimer's disease: A comprehensive review

Righi D, Manco C, Pardini M, Stufano A, Schino V, Pelagotti V, Massa F, Stefano N, Plantone D.

J Alzheimers Dis. 2025 Jan;103(1):38-55. doi: 10.1177/13872877241298973. Epub 2024 Nov 18.

The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease

Salminen A.

J Mol Med (Berl). 2025 Jan;103(1):1-19. doi: 10.1007/s00109-024-02504-x. Epub 2024 Nov 27.

Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer's Disease: Possible Mechanisms and Therapeutic Implications

Chauhan P, Begum MY, Narapureddy BR, Gupta S, Wadhwa K, Singh G, Kumawat R, Sharma N, Ballal S, Jha SK, Abomughaid MM, B D, Ojha S, Jha NK.

Mol Neurobiol. 2025 May;62(5):5850-5874. doi: 10.1007/s12035-024-04535-4. Epub 2024 Dec 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias